1. |
Yan W, Xiao Z, Lei L, et al. Novel needle immersed vitrification: a practical and convenient method with potential advantages in mouse and human ovarian tissue cryopreservation. Human Reproduction, 2008, 23(10): 2256-2265.
|
2. |
Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod, 1986, 1(2): 81-87.
|
3. |
Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol, 2006, 24(36): 5769-5577.
|
4. |
De Bruin ML, Huisbrink J, Hauptmann M, et al. Treatment-related risk factors for premature menopause following Hodgkin’s lymphoma. Blood, 2007, 111(1): 101-108.
|
5. |
Cvancarova M, Samuelsen SO, Magelssen H, et al. Reproduction rates after cancer treatment: experience from the Norwegian radium hospital. J Clin Oncol, 2009, 27(3): 334-343.
|
6. |
Maltaris T, Seufert R, Fischi F, et al. The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol, 2007, 130(2): 148-155.
|
7. |
Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv, 2007, 62(1): 58-72.
|
8. |
Madalinska JB, van Beurden M, Bleiker EM, et al. The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol, 2006, 24(22): 3576-3582.
|
9. |
Mah PM, Webster J, Jönsson P, et al. Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab, 2005, 90(11): 5964-5969.
|
10. |
Dahl SL, Chen Z, Solan AK, et al. Feasibility of vitrification as a storage method for tissue-engineered blood vessels. Tissue Eng, 2006, 12(2): 291-300.
|
11. |
Keros V, Xella S, Hultenby K, et al. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Hum Reprod, 2009, 24(7): 1670-1683.
|
12. |
Xiao Z, Wang Y, Li L, et al. Needle immersed vitrification can lower the concentration of cryoprotectant in human ovarian tissue cryopreservation. Fertil Steril, 2010, 94(6): 2323-2328.
|
13. |
Meirow D. Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers. Leuk Lymphoma, 1999, 33(1-2): 65-76.
|
14. |
Ataya KM, McKanna JA, Weintraub AM, et al. A luteinizing hormoe-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats. Cancer Res, 1985, 45(8): 3651-3656.
|
15. |
Letterie GS. Anovulation in the prevention of cytotoxic-induced follicular attrition and ovarian failure. Hum Reprod, 2004, 19(4): 831-837.
|
16. |
Meirow D, Assad G, Dor J, et al. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod, 2004, 19(6): 1294-1299.
|
17. |
Russel WR, Walpoe AL, Labhsetwar AP. Cyclophosphamide: induction of superovulation in rats. Nature, 1973, 241: 129-130.
|
18. |
Meirow D, Dor J, Kaufman B, et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod, 2007, 22(6): 1626-1633.
|
19. |
羅璐, 楊冬梓, 王箴, 等. 環磷酰胺對成年大鼠卵巢的損傷以及GnRHR 在卵巢的表達. 南方醫科大學學報, 2007, 27(11): 1714-1717.
|
20. |
羅滿林, 顧為望. 實驗動物學. 北京: 中國農業出版社, 2002: 145-149.
|
21. |
Ghosh S, Misro M, Das UB, et al. Effect of human chorionic gonadotrophin coadministration on ovarian steroidogenic and folliculogenic activities in cyclophosphamide treated albino rats. Reprod Toxicol, 2001, 15(2): 221-225.
|